160 related articles for article (PubMed ID: 12547911)
1. Quantitative imaging of the T cell antitumor response by positron-emission tomography.
Dubey P; Su H; Adonai N; Du S; Rosato A; Braun J; Gambhir SS; Witte ON
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1232-7. PubMed ID: 12547911
[TBL] [Abstract][Full Text] [Related]
2. Visualization of a primary anti-tumor immune response by positron emission tomography.
Shu CJ; Guo S; Kim YJ; Shelly SM; Nijagal A; Ray P; Gambhir SS; Radu CG; Witte ON
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17412-7. PubMed ID: 16293690
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
4. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
5. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
7. PET visualizes antitumor immune response.
J Nucl Med; 2006 Jan; 47(1):20N, 22N. PubMed ID: 17061395
[No Abstract] [Full Text] [Related]
8. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
Plater C; Debré P; Leclerc JC
Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
[TBL] [Abstract][Full Text] [Related]
11. T-cell regulation of erythropoiesis during acute lymphoblastic leukemia.
Bacon ER; Sing AP; Troutner JC; Reinisch CL
Exp Hematol; 1985 Feb; 13(2):104-10. PubMed ID: 3871705
[TBL] [Abstract][Full Text] [Related]
12. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
13. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
Gorczynski RM; Knight RA
Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
[TBL] [Abstract][Full Text] [Related]
16. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
17. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
18. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
19. High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: effect of gene transfer protocol on T cell homing receptor expression.
Zhou P; Lee J; Moore P; Brasky KM
Hum Gene Ther; 2001 Oct; 12(15):1843-55. PubMed ID: 11589827
[TBL] [Abstract][Full Text] [Related]
20. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
